Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Feasibility of the CorVad Percutaneous Ventricular Assist System in Refractory Right Heart Failure

NCT07704424 is registered in ClinicalTrials.gov with Shenzhen Core Medical Technology CO.,LTD. as lead sponsor.

NCT NCT07704424
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07704424 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Feasibility of the CorVad Percutaneous Ventricular Assist System in Refractory Right Heart Failure
Lead sponsor
Shenzhen Core Medical Technology CO.,LTD.
Phase
Not applicable
Overall status
Recruiting
Start date
June 2, 2026
Completion date
February 28, 2027
Enrollment
6 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

right heart failure